Health Care Select Sector SPDR (XLV)

At A Glance

You hold XLV in 0 portfolios

Price

128.69USD

 -2.64 -2.01%

2:30pm EDT

Category
Sector Equity
YTD Return (Cumulative)
 -8.66%
Classification
Health/Biotech
3 Year Return (Annualized)
 15.49%
52 Week High
$143.42
52 Week Low
$120.61
Lipper Leader Profile (Overall)
Total Return
Consistent Return
Capital Preservation
Low Expense
Tax Efficiency(U.S. only)

Growth of $10,000 over 10 years »

The Growth of $10,000 chart includes reinvestment of dividends and capital gains, but does not reflect the effect of any applicable sales or redemption charges which would lower these figures.

Total Return Performance (as of May 17, 2022)

Cumulative Performance
Fund or Index1 Day1 Week4 Weeks13 WeeksYTD1 Year
XLV 1.38% 3.52% 5.10% 1.01% 6.49% 8.14%

Lipper Hlth/Biotch Fd IX

 2.25% 4.59% 10.06% 10.06% 20.75% 16.01%
Percentile Rank
XLV vs. Category
99855771
Annualized Performance
3 Year5 Year10 YearSince Inception
XLV 16.16% 13.93% 15.60% 9.02%
Dec 16, 1998

Lipper Hlth/Biotch Fd IX

 7.88% 9.07% 13.83%--
Percentile Rank
XLV vs. Category
7716--

Quarter-To-Quarter

XLV
vs.
Equity Funds

Lipper Leaders Rating Overall

Total
Return
Consistent
Return
Capital
Preservation
ExpenseTax
Efficiency
Overview
Overall Rating
Peers with Rating*
99 Funds
99 Funds
12351 Funds
55 Funds
99 Funds

XLV Performance

1 Year
(Cumulative)
Category Range
SEC Performance
as of Apr 30, 2022
 9.03%
After Tax
Pre-Liquidation
as of Apr 30, 2022
 8.60%
After Tax
Post-Liquidation
as of Apr 30, 2022
 5.56%

Distributions

1 YR Dividend Income / Share(by US Dollar)

XLV returned $1.90 in dividend income over the past year which was  Above the median for the Sector Equity and is in the 67th percentile of funds in this category.
View Overview Page For